Related Experiment Video
Updated: May 25, 2026
06:43
Robotic Duodenal Sleeve Resection for Gastrointestinal Stromal Tumor with Rare Exon 8 KIT Mutation Following Neoadjuvant Imatinib
Published on: April 3, 2026
Pediatric gastrointestinal stromal tumor.
Katherine A Janeway1, Christopher B Weldon
1Department of Pediatric Oncology, Dana Farber Cancer Institute-Children's Hospital Boston, Boston, Massachusetts, USA.
Seminars in Pediatric Surgery
|January 18, 2012
Summary
Pediatric gastrointestinal stromal tumors (GIST) are rare and differ from adult GIST. Optimal management requires clinical trials at specialized centers due to evolving treatment understanding.
Area of Science:
- Pediatric Oncology
- Gastrointestinal Stromal Tumors (GIST)
- Rare Cancers
Background:
- Pediatric gastrointestinal stromal tumor (GIST) is a rare malignancy distinct from adult GIST.
- Limited understanding of GIST biology and oncogenesis in children necessitates specialized care.
- Current treatment lacks standardized guidelines for multimodality therapy.
Purpose of the Study:
- To provide a comprehensive review of pediatric GIST diagnosis and management.
- To discuss the oncogenesis and associated syndromes of pediatric GIST.
- To highlight the importance of clinical trials and multidisciplinary care for improved outcomes.
Main Methods:
- Comprehensive literature review on pediatric GIST.
- Analysis of current diagnostic and therapeutic approaches.
- Discussion of GIST biology, oncogenesis, and associated syndromes.
Main Results:
- Pediatric GIST presents unique characteristics compared to adult GIST.
- Surgery is the primary treatment, but optimal multimodality therapy is not standardized.
- Long-term survival is possible, emphasizing the need for ongoing management.
Conclusions:
- Pediatric GIST requires a specialized, multidisciplinary approach.
- Enrollment in clinical trials is crucial for advancing treatment strategies.
- Long-term follow-up at specialized centers is recommended for pediatric GIST patients.
